pandem
influenza
viru
caus
signific
outbreak
worldwid
last
year
number
oseltamivirresist
virus
possess
substitut
neuraminidas
na
protein
report
sporad
sever
countri
includ
japan
sensit
zanamivir
spread
commun
studi
monitor
rapidli
simpli
oseltamivirresist
virus
possess
duplex
onestep
rtpcr
assay
rtpcr
assay
develop
base
endpoint
genotyp
analysi
method
rtpcr
assay
evalu
use
sever
subtypestyp
influenza
b
virus
respiratori
pathogen
virus
shown
high
sensit
high
specif
fortyfour
clinic
specimen
test
rna
purif
use
rtpcr
assay
result
one
clinic
specimen
found
contain
viru
possess
mutat
seventythre
clinic
isol
test
assay
use
clinic
isol
cultur
supernat
cell
directli
without
rna
purif
result
consist
na
sequenc
sinc
rtpcr
assay
could
detect
mutat
clinic
isol
without
rna
purif
well
mutat
viru
clinic
specimen
rna
purif
assay
consid
power
tool
surveil
screen
oseltamivirresist
viru
activ
substitut
neuraminidas
na
protein
report
sporad
sever
countri
includ
japan
sensit
zanamivir
spread
commun
studi
monitor
rapidli
simpli
oseltamivirresist
virus
possess
duplex
onestep
rtpcr
assay
rtpcr
assay
develop
base
endpoint
genotyp
analysi
method
rtpcr
assay
evalu
use
sever
subtypestyp
influenza
b
virus
respiratori
pathogen
virus
shown
high
sensit
high
specif
fortyfour
clinic
specimen
test
rna
purif
use
rtpcr
assay
result
one
clinic
specimen
found
contain
viru
possess
mutat
seventythre
clinic
isol
test
assay
use
clinic
isol
cultur
supernat
cell
directli
without
rna
purif
result
consist
na
sequenc
sinc
rtpcr
assay
could
detect
mutat
clinic
isol
without
rna
purif
well
mutat
viru
clinic
specimen
rna
purif
assay
consid
power
tool
surveil
screen
oseltamivirresist
novel
subtyp
influenza
viru
pandem
influenza
viru
spread
worldwid
sinc
identifi
mexico
unit
state
march
april
garten
et
al
smith
et
al
b
initi
character
pandem
influenza
viru
isol
show
suscept
neuraminidas
inhibitor
nai
zanamivir
oseltamivir
resist
ion
channel
blocker
adamantan
therefor
nai
especi
oseltamivir
pharmaceut
option
prophylact
drug
addit
support
inform
may
found
onlin
version
articl
author
declar
potenti
conflict
interest
relev
articl
therapeut
drug
administ
virusinfect
individu
introduct
two
nai
clinic
use
low
rate
resist
virus
subtyp
strain
observ
influenza
season
monto
et
al
kramarz
et
al
tashiro
et
al
howev
influenza
season
novemb
oseltamivirresist
season
influenza
virus
possess
substitut
neuraminidas
na
protein
histidin
tyrosin
residu
posit
isol
predominantli
eu
countri
influenza
season
oseltamivirresist
virus
spread
dramat
worldwid
includ
japan
lackenbi
et
al
meijer
et
al
ujik
et
al
http
wwwwhointcsrdiseas
influenza
season
virus
spread
worldwid
replac
season
influenza
virus
oseltamivirresist
virus
possess
substitut
na
protein
report
sporad
sever
countri
includ
japan
april
http
wwwwhointcsrdiseaseswineflu
nai
surveil
japan
clinic
isol
sequenc
identif
substitut
marker
na
gene
oseltamivirresist
virus
possess
substitut
found
april
http
idscnihgojp
oseltamivirresist
virus
caus
local
epidem
japan
oseltamivirresist
virus
isol
case
administ
prophylact
therapeut
point
oseltamivir
use
associ
emerg
oseltamivirresist
virus
baz
et
al
current
detect
oseltamivirresist
virus
japan
perform
partial
sequenc
na
gene
clinic
isol
identifi
substitut
marker
follow
na
inhibit
assay
use
chemiluminesc
system
method
howev
requir
skill
involv
labori
procedur
studi
monitor
rapidli
simpli
oseltamivirresist
virus
possess
duplex
rtpcr
assay
rtpcr
assay
develop
use
endpoint
genotyp
analysi
method
assay
could
discrimin
oseltamivirresist
viru
possess
mutat
clinic
specimen
rna
purif
requir
use
assay
detect
mutat
clinic
specimen
sinc
specimen
nasal
nasopharyng
swab
may
contain
compon
inhibit
rtpcr
reaction
assay
also
could
detect
mutat
clinic
isol
cultur
supernat
directli
without
rna
purif
sinc
rna
purif
procedur
sampl
increas
risk
crosscontamin
timeconsum
abil
perform
assay
without
rna
purif
advantag
situat
larg
number
clinic
isol
handl
assay
develop
studi
use
tool
monitor
oseltamivirresist
virus
nucleotid
sequenc
na
gene
virus
post
global
initi
share
avian
influenza
data
gisaid
databas
august
octob
align
use
clustal
w
softwar
larkin
et
al
base
sequenc
two
probe
detect
oseltamivirsuscept
oseltamivirresist
design
discrimin
c
nucleotid
posit
na
gene
respect
primer
probe
sequenc
list
tabl
influenza
virus
isol
clinic
specimen
use
madindarbi
canin
kidney
mdck
cell
caco
cell
human
colon
carcinoma
cell
type
subtyp
clinic
isol
determin
hemagglutin
inhibit
hi
test
clinic
isol
influenza
virus
nasal
pharyng
swab
collect
suspect
contact
case
influenza
suspend
viru
transport
medium
obtain
hospit
clinic
japan
specimen
collect
septemb
februari
studi
protocol
approv
ethic
committe
niid
studi
perform
complianc
declar
helsinki
inform
consent
obtain
patient
supernat
cultur
mdck
cell
inocul
influenza
virus
clarifi
centrifug
min
viral
rna
prepar
ml
supernat
use
qiaamp
viral
rna
kit
qiagen
duesseldorf
germani
accord
manufactur
instruct
except
viral
rna
elut
ml
ave
qiagen
total
rna
prepar
clinic
specimen
use
qiaamp
viral
rna
kit
qiagen
use
ml
clinic
specimen
magmax
tm
viral
isol
kit
ambion
austin
tx
use
ml
clinic
specimen
kingfish
flex
thermo
fisher
scientif
waltham
accord
manufactur
instruct
total
rna
ml
clinic
specimen
elut
ml
ave
qiagen
wherea
total
rna
ml
clinic
specimen
elut
ml
elut
buffer
ambion
reaction
perform
use
quantitect
viru
rox
vial
kit
qiagen
accord
manufactur
instruct
briefli
test
clinic
isol
use
cultur
medium
ml
assay
contain
ml
quantitect
viru
nr
master
mix
ml
quantitect
viru
rt
mix
ml
mm
forward
primer
ml
mm
revers
primer
ml
two
mm
probe
rtpcr
ml
mm
probe
type
rrtpcr
ml
ml
water
ml
cultur
medium
test
clinic
specimen
use
extract
rna
ml
rna
templat
use
cycl
perform
follow
min
activ
rt
follow
initi
denatur
min
subsequ
cycl
amplif
denatur
sec
anneal
well
extens
sec
use
lightcycl
roch
basel
switzerland
fluoresc
signal
collect
anneal
extens
step
amplif
data
endpoint
data
analyz
use
light
cycler
softwar
accord
manufactur
instruct
evalu
sensit
rtpcr
assay
influenza
viru
detect
assay
simplex
realtim
rtpcr
assay
design
type
rrtpcr
assay
perform
use
previous
design
primer
probe
correspond
conserv
region
matrix
gene
segment
control
nakauchi
et
al
confirm
subtyp
influenza
viru
clinic
specimen
test
simplex
realtim
rtpcr
assay
detect
specif
viru
rrtpcr
assay
describ
previous
nakauchi
et
al
amplifi
partial
na
gene
start
codon
use
extract
rna
isol
viru
rtpcr
carri
follow
pair
primer
swine
swine
tabl
use
onestep
rna
pcr
kit
amv
takara
tokyo
japan
accord
manufactur
instruct
rtpcr
condit
follow
min
activ
rt
follow
initi
denatur
min
subsequ
cycl
amplif
denatur
sec
anneal
sec
extens
min
pcr
product
purifi
sequenc
use
swine
primer
bigdy
termin
cycl
sequenc
kit
appli
biosystem
carlsbad
ca
appli
biosystem
dna
analyz
total
rna
prepar
describ
rna
prepar
section
specif
duplex
endpoint
genotyp
rtpcr
assay
detect
oseltamivirresist
viru
rtpcr
evalu
use
human
season
influenza
virus
influenza
b
virus
viral
respiratori
pathogen
rtpcr
assay
react
specif
virus
show
crossreact
subtypestyp
influenza
b
virus
viral
respiratori
pathogen
data
shown
sensit
rtpcr
assay
compar
type
rrtpcr
assay
use
serial
dilut
pdm
pdm
virus
six
replic
assay
shown
tabl
ii
minimum
viral
titer
detect
pdm
adenmark
pdm
use
type
rrtpcr
rtpcr
assay
reaction
respect
endpoint
fluoresc
plot
rtpcr
fig
standard
curv
type
rrtpcr
assay
also
gener
fig
c
standard
curv
show
linear
relationship
log
viral
titer
cross
point
cp
valu
fig
fig
correl
coeffici
standard
curv
indic
precis
loglinear
relationship
viral
titer
cp
valu
fig
c
octob
februari
clinic
specimen
nasal
pharyng
swab
nasal
aspir
suspect
case
viru
infect
n
obtain
hospit
clinic
japan
clinic
specimen
test
type
rrtpcr
assay
rna
purif
clinic
specimen
clinic
specimen
confirm
posit
type
clinic
specimen
confirm
neg
type
tabl
iii
type
aand
clinic
specimen
test
rtpcr
assay
specimen
determin
oseltamivirsuscept
specimen
determin
oseltamivirresist
tabl
iii
five
type
aand
clinic
specimen
confirm
neg
rtpcr
assay
tabl
iii
result
also
shown
endpoint
fluoresc
plot
fig
facilit
assay
scheme
rtpcr
assay
perform
use
cultur
supernat
infect
mdck
cell
directli
without
rna
purif
templat
assay
screen
mutat
larg
number
clinic
isol
twentyfour
clinic
isol
possess
clinic
isol
possess
clinic
isol
combin
virus
possess
use
directli
valid
rtpcr
assay
without
rna
purif
three
isol
season
influenza
virus
possess
three
isol
season
influenza
virus
possess
also
use
directli
neg
control
rtpcr
assay
without
rna
purif
isol
season
influenza
virus
show
crossreact
neg
assay
fig
assay
isol
virus
possess
confirm
fig
result
clinic
isol
shown
fig
respect
four
clinic
isol
combin
virus
confirm
mix
fig
studi
rapid
simpl
duplex
onestep
endpoint
genotyp
rtpcr
assay
discrimin
virus
possess
mutat
rtpcr
assay
develop
sensit
rtpcr
assay
compar
type
rrtpcr
assay
tabl
ii
detect
limit
copiesreact
nakauchi
et
al
crossreact
nonspecif
reaction
observ
assay
perform
use
subtypestyp
influenza
virus
fig
clinic
specimen
tabl
iii
fig
result
demonstr
rtpcr
assay
highli
specif
sensit
detect
mutat
use
rtpcr
assay
purifi
rna
clinic
specimen
test
tabl
iii
fig
clinic
specimen
test
posit
type
tabl
iii
fig
among
specimen
rtpcr
assay
detect
oseltamivirsuscept
virus
oseltamivirresist
viru
result
correspond
na
sequenc
discrep
rtpcr
assay
na
sequenc
suggest
rtpcr
assay
could
discrimin
virus
possess
clinic
specimen
clinic
isol
cultur
supernat
mdck
cell
fig
use
directli
rtpcr
assay
without
rna
purif
assay
result
compar
result
na
sequenc
discrep
found
analyz
rtpcr
assay
viral
titer
two
isol
repres
centerlin
plot
respect
plot
gener
use
averag
result
obtain
assay
perform
six
replic
rel
vic
fam
fluoresc
plot
yaxi
xaxi
respect
b
c
serial
dilut
b
c
analyz
type
rrtpcr
assay
standard
curv
gener
use
averag
cross
point
cp
valu
obtain
assay
perform
six
replic
correl
coeffici
slope
standard
curv
repres
graph
fig
found
mix
popul
virus
possess
sequenc
na
gene
data
shown
detect
mix
rtpcr
assay
fig
result
suggest
rtpcr
assay
could
discrimin
specif
virus
possess
mix
noteworthi
rtpcr
assay
could
detect
mutat
clinic
isol
without
rna
purif
sinc
suffici
amount
viral
rna
may
releas
virion
rt
condit
min
consid
handl
larg
number
clinic
isol
rtpcr
assay
perform
rapidli
simpli
lower
risk
crosscontamin
rna
purif
unnecessari
recent
assay
develop
use
probe
contain
lna
nucleotid
discrimin
possess
van
der
vri
et
al
assay
highli
specif
result
interpret
easili
howev
oseltamivirresist
viru
evalu
assay
two
realtim
rtpcr
assay
also
develop
one
detect
virus
possess
detect
possess
hindiyeh
et
al
howev
two
independ
assay
describ
discrimin
simpl
interpret
result
costli
rtpcr
assay
develop
studi
could
perform
rapidli
simpli
sinc
cultur
supernat
infect
cell
use
directli
without
rna
purif
fig
endpoint
genotyp
analysi
program
light
cycler
softwar
interpret
result
assay
automat
use
posit
control
like
pdm
pdm
suggest
assay
use
screen
mutat
nai
surveil
activ
addit
rtpcr
assay
could
detect
whether
patient
infect
oseltamivirsuscept
resist
virus
test
clinic
specimen
suggest
assay
power
diagnost
method
determin
manag
patient
